Comparative Effects of Strain-counterstrain and Muscle Energy Techniques on Neck Pain and Functional Disability in Patients with Cervicogenic Headache
Not Applicable
Not yet recruiting
- Conditions
- Cervicogenic Headache
- Registration Number
- NCT06811766
- Lead Sponsor
- University of Faisalabad
- Brief Summary
The primary objective of this study is to compare effects of SCS and METs on reduction of neck pain intensity and improvement in functional disability in individuals with CGH. The secondary objective is to assess the impact of both techniques on ROM in cervical spine
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
- participants who fulfill the criteria of international headache society.
Exclusion Criteria
- participants who have cervicogenic headache after cervical injury or head surgery.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Neck disability index 3 weeks To check functional disability
Visual analogue scale 3 weeks To check pain intensity
- Secondary Outcome Measures
Name Time Method Goniometer 3 weeks To measure range of motion
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie SCS and METs in modulating cervical nociception and inflammation in CGH?
How do SCS and METs compare to standard-of-care physical therapy for CGH in pain reduction and functional disability improvement?
Which cervical spine biomarkers predict response to SCS versus METs in patients with CGH and comorbid myofascial trigger points?
What are the safety profiles and adverse event management strategies for SCS and METs in chronic CGH populations?
How effective are SCS/METs combination therapies with NSAIDs or muscle relaxants for CGH compared to monotherapies?